1. EachPod
EachPod
Expert Voices in Dementia - Podcast

Expert Voices in Dementia

Thought leaders from the field present insights from dementia research, clinical practice, and caregiving that will help you maximize the quality of life and well-being of your patients

Science Medicine Health & Fitness Education Life Sciences
Update frequency
every 16 days
Average duration
14 minutes
Episodes
20
Years Active
2024 - 2025
Share to:
Beyond Slowing Cognitive Decline: Patient and Caregiver Perspectives on Alzheimer’s Treatment

Beyond Slowing Cognitive Decline: Patient and Caregiver Perspectives on Alzheimer’s Treatment

This episode explores groundbreaking qualitative research from the University of Pennsylvania on patient and caregiver perspectives in Alzheimer disease. Dr. Katie Auriemma, Perelman School of Medici…

00:21:26  |   Tue 09 Sep 2025
Beyond the Boardroom: Barbara Corcoran on Caregiving and Alzheimer Disease

Beyond the Boardroom: Barbara Corcoran on Caregiving and Alzheimer Disease

In this episode, we are joined by entrepreneur and television personality, Barbara Corcoran. While many know Barbara for her business acumen and dynamic presence on Shark Tank, fewer may know the dee…
00:17:42  |   Thu 01 May 2025
Plasma P-Tau217: Detecting Alzheimer Disease with a Blood Test

Plasma P-Tau217: Detecting Alzheimer Disease with a Blood Test

Sterling Johnson, PhD, Associate Director and Biomarker Core Leader in the Wisconsin Alzheimer’s Disease Research Center (ADRC), and a Clinical Neuropsychologist and Neuroscientist focused on underst…
00:20:59  |   Fri 21 Mar 2025
Updated Criteria for Diagnosis and Staging of Alzheimer Disease: Recommendations of the International Working Group

Updated Criteria for Diagnosis and Staging of Alzheimer Disease: Recommendations of the International Working Group

Nicolas Villain, MD, PhD, Associate Professor of Neurology, Sorbonne University, Paris, France, discusses the International Working Group’s updated diagnostic criteria for the diagnosis and staging o…
00:11:31  |   Tue 25 Feb 2025
Blarcamesine: An Investigational Oral Drug for Alzheimer Disease

Blarcamesine: An Investigational Oral Drug for Alzheimer Disease

Timo Grimmer, MD, Associate Professor of Psychiatry and Psychotherapy and Head of the Centre for Cognitive Disorders at the Technical University of Munich, Germany, discusses the experimental oral sm…
00:16:27  |   Sat 25 Jan 2025
The CMS GUIDE Model To Support Patients with Dementia and Their Caregivers

The CMS GUIDE Model To Support Patients with Dementia and Their Caregivers

Sarena Ho, Health Insurance Specialist at the CMS Innovation Center, provides an overview on the Guiding an Improved Dementia Experience (GUIDE) Model, which helps physicians provide coordinated care…
00:10:42  |   Thu 19 Dec 2024
The BenfoTeam Clinical Trial: Investigating Benfotiamine as a Potential Therapy for Early Alzheimer Disease

The BenfoTeam Clinical Trial: Investigating Benfotiamine as a Potential Therapy for Early Alzheimer Disease

Gary E. Gibson, PhD, Professor of Neurosciences, Burke Neurological Institute, Weill Cornell Medicine, White Plains, NY, details his research related to metabolic changes associated with Alzheimer di…
00:15:41  |   Tue 19 Nov 2024
BrainCheck as a Digital Cognitive Assessment Tool

BrainCheck as a Digital Cognitive Assessment Tool

Kim Rodriguez, CEO of BrainCheck, provides an overview of the company's cognitive assessment plan and how clinicians can use these tools in practice. Learn more about your ad choices. Visit megaphone…
00:07:17  |   Fri 08 Nov 2024
Kramer, Van Dyck

Kramer, Van Dyck

Lynn D. Kramer, MD, FAAN, Chief Clinical Officer, Deep Human Biology Learning at Eisai and a member of the Eisai Executive Committee, and Christopher van Dyck, MD, Professor of Psychiatry, Neurology,…
00:12:18  |   Fri 27 Sep 2024
CSF, PET, and Blood-Based Biomarker Tests for Alzheimer Disease - Part 3

CSF, PET, and Blood-Based Biomarker Tests for Alzheimer Disease - Part 3

In this series, Suzanne Schindler, MD, PhD, Associate Professor of Neurology at Washington University School of Medicine in St. Louis, discusses cerebrospinal fluid, PET, and blood-based biomarker te…
00:10:14  |   Sat 21 Sep 2024
CSF, PET, and Blood-Based Biomarker Tests for Alzheimer Disease - Part 2

CSF, PET, and Blood-Based Biomarker Tests for Alzheimer Disease - Part 2

In this series, Suzanne Schindler, MD, PhD, Associate Professor of Neurology at Washington University School of Medicine in St. Louis, discusses cerebrospinal fluid, PET, and blood-based biomarker te…
00:17:02  |   Sat 21 Sep 2024
CSF, PET, and Blood-Based Biomarker Tests for Alzheimer Disease - Part 1

CSF, PET, and Blood-Based Biomarker Tests for Alzheimer Disease - Part 1

In this series, Suzanne Schindler, MD, PhD, Associate Professor of Neurology at Washington University School of Medicine in St. Louis, discusses cerebrospinal fluid, PET, and blood-based biomarker te…
00:08:53  |   Sat 21 Sep 2024
Labcorp's Biomarker Testing for Alzheimer Disease

Labcorp's Biomarker Testing for Alzheimer Disease

Joseph M. Volpe, MD, Discipline Director, Clinical Neuroscience, Labcorp, discusses biomarker testing for Alzheimer disease and dementia,, including current offerings, reimbursement, and future direc…
00:12:50  |   Mon 16 Sep 2024
What Neurologists Should Know About End-of-Life Care Discussions

What Neurologists Should Know About End-of-Life Care Discussions

Dan Morhaim, MD, board-certified emergency medicine and internal medicine physician, and former 24-year Maryland State Legislator, highlights the importance of discussing end-of-life care issues with…
00:20:47  |   Fri 19 Jul 2024
Insights into the Role of Tau in Alzheimer Disease and Neurodegenerative Disorders

Insights into the Role of Tau in Alzheimer Disease and Neurodegenerative Disorders

Virginia Man-Yee Lee, PhD, who serves as the John H. Ware 3rd Endowed Professor in Alzheimer's Research at the University of Pennsylvania Perelman School of Medicine, the Director of the Center for N…
00:22:07  |   Mon 15 Jul 2024
Strategies to Limit ARIA Associated with Alzheimer Disease Treatment

Strategies to Limit ARIA Associated with Alzheimer Disease Treatment

Dawn Brooks, PhD, Global Development Leader, Eli Lilly and Company, and John Sims, MD, Senior Medical Director, Eli Lilly and Company, discuss new findings on baseline characteristics about amyloid-r…
00:09:22  |   Mon 15 Jul 2024
Real-World Implications Beyond Cognition in Treating Alzheimer Disease Patients with Donanemab

Real-World Implications Beyond Cognition in Treating Alzheimer Disease Patients with Donanemab

Dawn Brooks, PhD, Global Development Leader, Eli Lilly and Company, and John Sims, MD, Senior Medical Director, Eli Lilly and Company, discuss recent data analyzing the real-world implications of don…
00:08:51  |   Mon 15 Jul 2024
Emerging Therapeutic Targets for Alzheimer Disease

Emerging Therapeutic Targets for Alzheimer Disease

Howard Fillit, MD, geriatrician, neuroscientist, and Chief Science Officer and Co-Founder of the Alzheimer's Drug Discovery Foundation, discusses the importance of research into new therapeutic targe…
00:14:27  |   Mon 15 Jul 2024
Progress in Diagnosis and Management of Neuropsychiatric Symptoms in People Living with Dementia

Progress in Diagnosis and Management of Neuropsychiatric Symptoms in People Living with Dementia

George Grossberg, MD, Samuel W. Fordyce Professor and Director of Geriatric Psychiatry, Saint Louis University School of Medicine, provides an overview of recent progress in the evaluation, diagnosis…
00:13:05  |   Sun 07 Jul 2024
How Healthcare Providers Can Partner with Caregivers of People Living with Dementia

How Healthcare Providers Can Partner with Caregivers of People Living with Dementia

Dementia care expert, gerontologist, and author, Laura Wayman provides insights into what caregivers for people living with dementia need from healthcare providers and how clinicians can best partner…
00:18:10  |   Sun 07 Jul 2024
Disclaimer: The podcast and artwork embedded on this page are the property of Bryn Mawr Communications (BMC). This content is not affiliated with or endorsed by eachpod.com.